600216.SS SHH
Zhejiang Medicine Co., Ltd.
1W: -2.3%
1M: -3.9%
3M: +6.2%
YTD: -23.0%
1Y: -20.1%
3Y: +16.9%
5Y: -8.2%
¥12.43 ($1.85)
+0.25 (+2.05%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$13.8B
+7.9% ▲
5Y CAGR: +5.9%
Total Liabilities
$2.9B
+4.8% ▲
5Y CAGR: +6.8%
Shareholders Equity
$10.6B
+10.6% ▲
5Y CAGR: +6.3%
Cash & Investments
$2.3B
+26.4% ▲
5Y CAGR: +7.1%
Total Debt
$442M
+2.5% ▲
5Y CAGR: -7.4%
Net Debt
-$1.5B
-131.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.6B | $1.8B | $1.4B | $1.5B | $2.0B |
| Short-Term Investments | $271M | $454M | $447M | $328M | $295M |
| Cash & ST Investments | $1.9B | $2.2B | $1.9B | $1.8B | $2.3B |
| Net Receivables | $1.4B | $1.7B | $1.5B | $1.7B | $2.0B |
| Inventory | $1.5B | $1.9B | $2.0B | $2.0B | $2.1B |
| Other Current Assets | $285M | $341M | $275M | $50M | $79M |
| Total Current Assets | $5.1B | $6.0B | $5.7B | $5.6B | $6.6B |
| Property, Plant & Equip. | $4.5B | $5.4B | $5.6B | $6.0B | $6.1B |
| Goodwill & Intangibles | $410M | $765M | $776M | $763M | $684M |
| Long-Term Investments | -$75M | -$328M | -$303M | -$162M | -$138M |
| Other Non-Current Assets | $448M | $623M | $609M | $476M | $418M |
| Total Non-Current Assets | $5.4B | $6.5B | $6.8B | $7.2B | $7.2B |
| Total Assets | $10.5B | $12.5B | $12.4B | $12.8B | $13.8B |
| — Liabilities — | |||||
| Accounts Payable | $699M | $1.4B | $316M | $1.1B | $1.1B |
| Short-Term Debt | $450M | $225M | $50M | $200M | $270M |
| Deferred Revenue | $772M | $950M | $62M | $0 | $0 |
| Other Current Liabilities | $3M | $406M | $1.4B | $419M | $340M |
| Total Current Liabilities | $1.9B | $3.0B | $2.5B | $2.5B | $2.6B |
| Long-Term Debt | $501M | $250M | $200M | $230M | $171M |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $82M |
| Total Non-Current Liabilities | $546M | $325M | $257M | $315M | $358M |
| Total Liabilities | $2.5B | $3.3B | $2.7B | $2.8B | $2.9B |
| — Equity — | |||||
| Common Stock | $965M | $965M | $965M | $965M | $962M |
| Retained Earnings | $4.0B | $4.7B | $4.8B | $5.0B | $5.9B |
| Accumulated OCI | $2.1B | $2.1B | $2.4B | $6M | $2.7B |
| Total Stockholders Equity | $7.7B | $8.8B | $9.3B | $9.6B | $10.6B |
| Total Liabilities & Equity | $10.5B | $12.5B | $12.4B | $12.8B | $13.8B |
| — Key Metrics — | |||||
| Total Debt | $951M | $878M | $802M | $431M | $442M |
| Net Debt | -$678M | -$890M | -$636M | -$659M | -$1.5B |
| Total Investments | $195M | $126M | $145M | $166M | $157M |